Michael Kastan began working on DNA-damage response as a graduate student more than 20 years ago. In this issue, the hematology-oncology chair at St. Jude Children's Research Hospital writes about the promise of manipulating DNA-repair mechanisms to target more than cancer (
Jo Handelsman, who writes on